Date Filed | Type | Description |
03/06/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
03/01/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
02/22/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
02/22/2023 |
POSASR
| Form POSASR - Post-effective Amendment to an automatic shelf registration statement: |
02/22/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
02/22/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
02/22/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
02/22/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
02/22/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
02/22/2023 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disp... |
02/22/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
02/21/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
02/21/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
02/21/2023 |
8-K
| Quarterly results |
02/14/2023 |
SC 13G/A
| TIGER GLOBAL MANAGEMENT LLC reports a 0% stake in 1Life Healthcare, Inc. |
02/10/2023 |
SC 13G/A
| Temasek Holdings Ltd reports a 0% stake in 1Life Healthcare, Inc. |
02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 8.4% stake in 1Life Healthcare Inc. |
02/08/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
11/15/2022 |
8-K
| Quarterly results |
11/02/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
11/02/2022 |
8-K
| Quarterly results |
09/15/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
09/07/2022 |
8-K/A
| Other Events Interactive Data |
09/02/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
09/02/2022 |
8-K
| Other Events |
08/09/2022 |
PREM14A
| Form PREM14A - Preliminary proxy statements relating to merger or acquisition: |
08/04/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
08/03/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
08/03/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
08/03/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
08/03/2022 |
8-K
| Quarterly results |
08/01/2022 |
SC 13G/A
| FMR LLC reports a 2.2% stake in 1LIFE HEALTHCARE INC |
07/21/2022 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
07/21/2022 |
8-K
| Quarterly results |
|